Zdrowie i gospodarka · 06/09/2024

FDA Announces Draft Guidance on Incorporating Patient Preference Information into Product Life Cycle

The US Food and Drug Administration (FDA) has released a draft guidance outlining how patient preference information (PPI) can be used across the entire life cycle of medical products, from initial review to post-market approval, and how it can be incorporated into product labeling and decision-making processes.